143 related articles for article (PubMed ID: 17527092)
1. Prevalence of and factors associated with hepatic steatosis in patients coinfected with hepatitis C virus and HIV: Agence Nationale pour la Recherche contre le SIDA et les hépatites virales CO3 Aquitaine Cohort.
Neau D; Winnock M; Castéra L; Bail BL; Loko MA; Géraut L; Dupon M; Ragnaud JM; Lacoste D; Lafon ME; Bioulac-Sage P; Dabis F;
J Acquir Immune Defic Syndr; 2007 Jun; 45(2):168-73. PubMed ID: 17527092
[TBL] [Abstract][Full Text] [Related]
2. Psychiatric and substance use disorders in HIV/hepatitis C virus (HCV)-coinfected patients: does HCV clearance matter? [Agence Nationale de Recherche sur le SIDA et les Hépatites Virales (ANRS) HEPAVIH CO13 cohort].
Michel L; Lions C; Winnock M; Lang JP; Loko MA; Rosenthal E; Marchou B; Valantin MA; Morlat P; Roux P; Sogni P; Spire B; Poizot-Martin I; Lacombe K; Lascoux-Combe C; Duvivier C; Neau D; Dabis F; Salmon-Ceron D; Carrieri MP;
HIV Med; 2016 Nov; 17(10):758-765. PubMed ID: 27187027
[TBL] [Abstract][Full Text] [Related]
3. Histological findings and clinical characteristics associated with hepatic steatosis in patients coinfected with HIV and hepatitis C virus.
Marks KM; Petrovic LM; Talal AH; Murray MP; Gulick RM; Glesby MJ
J Infect Dis; 2005 Dec; 192(11):1943-9. PubMed ID: 16267765
[TBL] [Abstract][Full Text] [Related]
4. [Factors associated with hepatic steatosis in human immunodeficiency virus and hepatits C virus coinfected patients].
Pascual Pareja JF; Camino A; Larrauri J; López-Diéguez M; Montes ML; González-García J; Peña JM; Díez J; Arribas JR
Med Clin (Barc); 2009 Feb; 132(6):208-13. PubMed ID: 19237003
[TBL] [Abstract][Full Text] [Related]
5. Hepatic steatosis in HIV-HCV coinfected patients: analysis of risk factors.
Bani-Sadr F; Carrat F; Bedossa P; Piroth L; Cacoub P; Perronne C; Degott C; Pol S;
AIDS; 2006 Feb; 20(4):525-31. PubMed ID: 16470116
[TBL] [Abstract][Full Text] [Related]
6. Incidence and risk factors for steatosis progression in adults coinfected with HIV and hepatitis C virus.
Woreta TA; Sutcliffe CG; Mehta SH; Brown TT; Higgins Y; Thomas DL; Torbenson MS; Moore RD; Sulkowski MS
Gastroenterology; 2011 Mar; 140(3):809-17. PubMed ID: 21134375
[TBL] [Abstract][Full Text] [Related]
7. Hepatic steatosis in HIV/hepatitis C coinfection: prevalence and significance compared with hepatitis C monoinfection.
Monto A; Dove LM; Bostrom A; Kakar S; Tien PC; Wright TL
Hepatology; 2005 Aug; 42(2):310-6. PubMed ID: 16025515
[TBL] [Abstract][Full Text] [Related]
8. HIV coinfection and antiretroviral therapy enhances liver steatosis in patients with hepatitis C, but only in those infected by HCV genotype other than 3.
Borghi V; Puoti M; Mussini C; Bellelli S; Angeletti C; Sabbatini F; Prati F; Cossarizza A; Esposito R
Antivir Ther; 2008; 13(8):1057-65. PubMed ID: 19195331
[TBL] [Abstract][Full Text] [Related]
9. Hepatic steatosis in patients coinfected with human immunodeficiency virus/hepatitis C virus: a meta-analysis of the risk factors.
Machado MV; Oliveira AG; Cortez-Pinto H
Hepatology; 2010 Jul; 52(1):71-8. PubMed ID: 20578130
[TBL] [Abstract][Full Text] [Related]
10. Hepatic steatosis in HIV-HCV coinfected patients in France: comparison with HCV monoinfected patients matched for body mass index and HCV genotype.
Castéra L; Loko MA; Le Bail B; Coffie P; De Ledinghen V; Trimoulet P; Winnock M; Dabis F; Neau D;
Aliment Pharmacol Ther; 2007 Dec; 26(11-12):1489-98. PubMed ID: 17903235
[TBL] [Abstract][Full Text] [Related]
11. Hepatic steatosis is associated with fibrosis, nucleoside analogue use, and hepatitis C virus genotype 3 infection in HIV-seropositive patients.
McGovern BH; Ditelberg JS; Taylor LE; Gandhi RT; Christopoulos KA; Chapman S; Schwartzapfel B; Rindler E; Fiorino AM; Zaman MT; Sax PE; Graeme-Cook F; Hibberd PL
Clin Infect Dis; 2006 Aug; 43(3):365-72. PubMed ID: 16804853
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and Predictors of Hepatic Steatosis in Patients with HIV/HCV Coinfection and the Impact of HCV Eradication.
Chromy D; Mandorfer M; Bucsics T; Schwabl P; Bauer D; Scheiner B; Schmidbauer C; Lang GF; Szekeres T; Ferenci P; Trauner M; Reiberger T
AIDS Patient Care STDS; 2019 May; 33(5):197-206. PubMed ID: 31067123
[TBL] [Abstract][Full Text] [Related]
13. Impact of human immunodeficiency virus infection on the prevalence and severity of steatosis in patients with chronic hepatitis C virus infection.
Gaslightwala I; Bini EJ
J Hepatol; 2006 Jun; 44(6):1026-32. PubMed ID: 16618518
[TBL] [Abstract][Full Text] [Related]
14. [Liver transplantation for patients infected with both HIV and HCV or HIV and HBV].
Duclos-Vallée JC; Teicher E; Vittecoq D; Samuel D
Med Sci (Paris); 2007; 23(8-9):723-8. PubMed ID: 17875290
[TBL] [Abstract][Full Text] [Related]
15. Hepatic steatosis progresses faster in HIV mono-infected than HIV/HCV co-infected patients and is associated with liver fibrosis.
Pembroke T; Deschenes M; Lebouché B; Benmassaoud A; Sewitch M; Ghali P; Wong P; Halme A; Vuille-Lessard E; Pexos C; Klein MB; Sebastiani G
J Hepatol; 2017 Oct; 67(4):801-808. PubMed ID: 28527666
[TBL] [Abstract][Full Text] [Related]
16. Steatohepatitis: Risk factors and impact on disease severity in human immunodeficiency virus/hepatitis C virus coinfection.
Sterling RK; Contos MJ; Smith PG; Stravitz RT; Luketic VA; Fuchs M; Shiffman ML; Sanyal AJ
Hepatology; 2008 Apr; 47(4):1118-27. PubMed ID: 18366118
[TBL] [Abstract][Full Text] [Related]
17. Hepatic steatosis and antiretroviral drug use among adults coinfected with HIV and hepatitis C virus.
Sulkowski MS; Mehta SH; Torbenson M; Afdhal NH; Mirel L; Moore RD; Thomas DL
AIDS; 2005 Mar; 19(6):585-92. PubMed ID: 15802977
[TBL] [Abstract][Full Text] [Related]
18. HAART is associated with lower hepatic necroinflammatory activity in HIV-hepatitis C virus-coinfected patients with CD4 cell count of more than 350 cells/microl at the time of liver biopsy.
Pascual-Pareja JF; Caminoa A; Larrauri C; González-García J; Montes ML; Díez J; Grande M; Arribas JR
AIDS; 2009 May; 23(8):971-5. PubMed ID: 19425223
[TBL] [Abstract][Full Text] [Related]
19. Hepatic steatosis in HIV-HCV coinfected patients receiving antiretroviral therapy is associated with HCV-related factors but not antiretrovirals.
Martinez V; Ta TD; Mokhtari Z; Guiguet M; Miailhes P; Valantin MA; Charlotte F; Bertheau P; Molina JM; Katlama C; Caumes E
BMC Res Notes; 2012 Jul; 5():180. PubMed ID: 22490728
[TBL] [Abstract][Full Text] [Related]
20. Absence of liver steatosis in HIV-HCV co-infected patients receiving regimens containing tenofovir or abacavir.
Borghi V; Bisi L; Manzini L; Cossarizza A; Mussini C
Infection; 2013 Apr; 41(2):425-9. PubMed ID: 23225268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
